Miejski Szpital Zespolony w Olsztynie
About Miejski Szpital Zespolony w Olsztynie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bristol-Myers Squibb
2
Celgene
1
Eli Lilly and Company
1
Clinical Trials at Miejski Szpital Zespolony w Olsztynie
During the past decade, Miejski Szpital Zespolony w Olsztynie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
2017-11-27
2018-12-12
Completed
615
Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis
2018-08-07
2020-09-02
Completed
666
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
2019-08-12
2026-07-26
Active, not recruiting
1,452
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis
2021-05-14
2022-11-09
Completed
214
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Miejski Szpital Zespolony w Olsztynie"
#1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Miejski Szpital Zespolony w Olsztynie
According to Clinical.Site data, the most researched conditions in "Miejski Szpital Zespolony w Olsztynie" are
"Psoriasis" (2 trials), "Atopic Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Miejski Szpital Zespolony w Olsztynie" in a lesser frequency.
Clinical Trials Intervention Types at Miejski Szpital Zespolony w Olsztynie
Most popular intervention types in "Miejski Szpital Zespolony w Olsztynie" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "BMS-986165" (2 trials), "Apremilast" (1 trials), "Baricitinib" (1 trials) and "CC-93538" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Miejski Szpital Zespolony w Olsztynie
The vast majority of trials in "Miejski Szpital Zespolony w Olsztynie" are
4 trials for "All" genders.
Clinical Trials Status at Miejski Szpital Zespolony w Olsztynie
Currently, there are NaN active trials in "Miejski Szpital Zespolony w Olsztynie".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Miejski Szpital Zespolony w Olsztynie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Miejski Szpital Zespolony w Olsztynie, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".